Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Product News   Apr 28, 2017 | Original story from Cambridge Epigenetix

 
Cambridge Epigenetix Licenses Fundamental DNA Methylation IP from Boston Children’s Hospital

Anjana Rao. Credit: Cambridge Epigenetix

 
 
FURTHER INFORMATION
 
 
 

Related Product News

Agilent Introduces Real-Time PCR System for Clinical Diagnostics in Europe

Product News

Agilent Technologies launches real-time PCR system, expanding its portfolio of instruments for molecular diagnostics in Europe.

READ MORE

Festo to Showcase Laboratory Automation Innovations at AACC 2017

Product News

At the San Diego Convention Center, Festo will showcase new vial capping/de-capping option for PerkinElmer’s JANUS® series of automated liquid handling solutions.

READ MORE

Chromatrap Announce Native ChIP Kit for Mass Spectrometry

Product News

Chromatrap announces new native ChIP kit to eliminate the use of magnetic or agarose beads to quickly and easily recover purified chromatin for downstream applications, including mass spectroscopy.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research Diagnostics Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE